These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy. Pölzl G; Altenberger J; Baholli L; Beltrán P; Borbély A; Comin-Colet J; Delgado JF; Fedele F; Fontana A; Fruhwald F; Giamouzis G; Giannakoulas G; Garcia-González MJ; Gustafsson F; Kaikkonen K; Kivikko M; Kubica J; von Lewinski D; Löfman I; Malfatto G; Manito N; Martínez-Sellés M; Masip J; Merkely B; Morandi F; Mølgaard H; Oliva F; Pantev E; Papp Z; Perna GP; Pfister R; Piazza V; Bover R; Rangel-Sousa D; Recio-Mayoral A; Reinecke A; Rieth A; Sarapohja T; Schmidt G; Seidel M; Störk S; Vrtovec B; Wikström G; Yerly P; Pollesello P Int J Cardiol; 2017 Sep; 243():389-395. PubMed ID: 28571618 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial. Altenberger J; Parissis JT; Costard-Jaeckle A; Winter A; Ebner C; Karavidas A; Sihorsch K; Avgeropoulou E; Weber T; Dimopoulos L; Ulmer H; Poelzl G Eur J Heart Fail; 2014 Aug; 16(8):898-906. PubMed ID: 24920349 [TBL] [Abstract][Full Text] [Related]
6. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. Packer M; Colucci W; Fisher L; Massie BM; Teerlink JR; Young J; Padley RJ; Thakkar R; Delgado-Herrera L; Salon J; Garratt C; Huang B; Sarapohja T; JACC Heart Fail; 2013 Apr; 1(2):103-11. PubMed ID: 24621834 [TBL] [Abstract][Full Text] [Related]
7. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis. Silvetti S; Nieminen MS Int J Cardiol; 2016 Jan; 202():138-43. PubMed ID: 26386941 [TBL] [Abstract][Full Text] [Related]
8. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden. Thorvaldsen T; Benson L; Hagerman I; Dahlström U; Edner M; Lund LH Int J Cardiol; 2014 Jul; 175(1):55-61. PubMed ID: 24820737 [TBL] [Abstract][Full Text] [Related]
9. Advances in chemical pharmacotherapy for managing acute decompensated heart failure. Yandrapalli S; Tariq S; Aronow WS Expert Opin Pharmacother; 2017 Apr; 18(5):471-485. PubMed ID: 28276970 [TBL] [Abstract][Full Text] [Related]
10. Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. Bonios MJ; Terrovitis JV; Drakos SG; Katsaros F; Pantsios C; Nanas SN; Kanakakis J; Alexopoulos G; Toumanidis S; Anastasiou-Nana M; Nanas JN Int J Cardiol; 2012 Sep; 159(3):225-9. PubMed ID: 21481958 [TBL] [Abstract][Full Text] [Related]
11. Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan. Agostoni P; Farmakis DT; García-Pinilla JM; Harjola VP; Karason K; von Lewinski D; Parissis J; Pollesello P; Pölzl G; Recio-Mayoral A; Reinecke A; Yerly P; Zima E Card Fail Rev; 2019 Nov; 5(3):155-161. PubMed ID: 31768272 [TBL] [Abstract][Full Text] [Related]
12. Pulsed Levosimendan in advanced heart failure due to congenital heart disease: a case series. Cranley J; Hardiman A; Freeman LJ Eur Heart J Case Rep; 2020 Jun; 4(3):1-6. PubMed ID: 32617515 [TBL] [Abstract][Full Text] [Related]
13. Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period. Papadopoulou EF; Mavrogeni SI; Dritsas A; Cokkinos DV Hellenic J Cardiol; 2009; 50(4):269-74. PubMed ID: 19622496 [TBL] [Abstract][Full Text] [Related]
14. Levosimendan: a review of its use in the management of acute decompensated heart failure. Innes CA; Wagstaff AJ Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085 [TBL] [Abstract][Full Text] [Related]
15. Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus. Nieminen MS; Altenberger J; Ben-Gal T; Böhmer A; Comin-Colet J; Dickstein K; Edes I; Fedele F; Fonseca C; García-González MJ; Giannakoulas G; Iakobishvili Z; Jääskeläinen P; Karavidas A; Kettner J; Kivikko M; Lund LH; Matskeplishvili ST; Metra M; Morandi F; Oliva F; Parkhomenko A; Parissis J; Pollesello P; Pölzl G; Schwinger RH; Segovia J; Seidel M; Vrtovec B; Wikström G Int J Cardiol; 2014 Jun; 174(2):360-7. PubMed ID: 24780540 [TBL] [Abstract][Full Text] [Related]
16. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis. Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934 [TBL] [Abstract][Full Text] [Related]
17. Intermittent levosimendan infusions in advanced heart failure: a real world experience. Ortis B; Villani A; Oldani M; Giglio A; Ciambellotti F; Facchini M; Parati G; Malfatto G J Int Med Res; 2017 Feb; 45(1):361-371. PubMed ID: 28222634 [TBL] [Abstract][Full Text] [Related]
18. Repetitive infusion of levosimendan in patients with chronic heart failure: a meta-analysis. Yi GY; Li JX; Zhang J; Niu LL; Zhang CY Med Sci Monit; 2015 Mar; 21():895-901. PubMed ID: 25811545 [TBL] [Abstract][Full Text] [Related]
19. Levosimendan in daily intensive care practice--the experience of 15 centers. Background, methods and organization of the PORTLAND study. Cardoso JS; Ferreira J; de Sá EP; de Campos JM; Fonseca C; Lousada N; Moreira JI; Rabaçal C; Damasceno A; Seabra-Gomes R; Ferreira R; Abreu e Lima C Rev Port Cardiol; 2004 Nov; 23(11):1431-43. PubMed ID: 15693696 [TBL] [Abstract][Full Text] [Related]